Citi raised the firm’s price target on Kenvue (KVUE) to $24.50 from $22 and keeps a Neutral rating on the shares. The company reported “better-than-feared” Q1 results, the analyst tells investors in a research note. However, the firm says the company’s Q2 “looks a bit softer” with a later start to the allergy season and continued expected destocking.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KVUE: